Redeye comments on Xbrane following today's news that the FDA, like the EMA, has recieved positive f...
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) publicerade den 26 september 20...
Redeye comments on the news that Ngenic and Svea Solar entered a strategic partnership agreement wor...
Late last night, a bid for Doro at SEK 34, a bid premium of 38.
Nettoomsättningen uppgick till 49,2 MSEK (48,7) i det första kvartalet (maj-juli) i Purefuns brutna ...
Redeye comments on Optomed’s profit warning, where the company expects its revenues to decrease comp...
Redeye embraces the positive results from the SOLARIO trial, and we argue that the company has ticke...
Analyst Group betraktar Tellusgruppen som en väldiversifierad och stabil friskolekoncern med en robu...
CFO Rasmus Untidt appointed CEO with immediate effect Following past years' restructuring and stream...
Redeye comments on Modelon’s recently announced cost reduction program and organizational changes.
Redeye comments on last night's selling from two of Truecaller's largest shareholders (Kleiner Perki...
Redeye keeps its Base Case and forecasts unchanged.
Redeye is encouraged by yesterday’s announcement that Powercell has received another major order fro...
Q3 report due 24 October, we evaluate D2C potential We forecast net sales of SEK 186m, EBITA of SEK ...
Redeye provides a short comment on Episurf's announcement about the revised estimated timeline for F...
Aptahem har gjort stora framsteg med läkemedelskandidaten Apta-1 för behandling av svåra inflammator...
Clean Motion AB utvecklar hållbara transportlösningar för städer, med fokus på att minska koldioxidu...
Cibus, which raised EUR ~82m new equity two weeks ago to fund growth, announced after market close o...
Ramlösa shipping AB (”Ramlösa” eller ”Bolaget”) är ett investmentbolag med exponering mot sjöfartsma...
Redeye comments on Active Biotech’s rights issue of SEK35m with a subscription price of SEK 0.
